Rapamycin 42-ester with 3-hydroxy-2(hydroxymethyl)-2-methylpropionic acid as antineoplastic agent

Rapamycin 42-ester with 3-hydroxy-2(hydroxymethyl)-2-methylpropionic acid as antineoplastic agent

  • CN 102,058,588 A
  • Filed: 11/13/2001
  • Published: 05/18/2011
  • Est. Priority Date: 11/15/2000
  • Status: Active Application
First Claim
Patent Images

1. 3-rapamycin 42 esters of hydroxyl-2-(methylol)-2 Methylpropionic acid, being CCI-779 is used for the treatment of purposes in the medicine of the intractable tumor in the mammal in preparation, and wherein said intractable tumor is selected from neuroendocrine tumor, head and the neck cancer of breast carcinoma, lung.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×